|1||Active, not recruiting||
Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
|2||Active, not recruiting||
AMP-224, a PD-1 Inhibitor, in Combination With Stereotactic Body Radiation Therapy in People With Metastatic Colorectal Cancer
A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031)
Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
† Study has passed its completion date and status has not been verified in more than two years.